Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo
- PMID: 35760871
- PMCID: PMC9711940
- DOI: 10.1038/s42255-022-00591-z
Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo
Abstract
Multiple roles of reactive oxygen species (ROS) and their consequences for health and disease are emerging throughout biological sciences. This development has led researchers unfamiliar with the complexities of ROS and their reactions to employ commercial kits and probes to measure ROS and oxidative damage inappropriately, treating ROS (a generic abbreviation) as if it were a discrete molecular entity. Unfortunately, the application and interpretation of these measurements are fraught with challenges and limitations. This can lead to misleading claims entering the literature and impeding progress, despite a well-established body of knowledge on how best to assess individual ROS, their reactions, role as signalling molecules and the oxidative damage that they can cause. In this consensus statement we illuminate problems that can arise with many commonly used approaches for measurement of ROS and oxidative damage, and propose guidelines for best practice. We hope that these strategies will be useful to those who find their research requiring assessment of ROS, oxidative damage and redox signalling in cells and in vivo.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures
References
-
- Halliwell B & Gutteridge JMC Free Radicals in Biology and Medicine 5th edn (Oxford Univ. Press, 2015).
-
- Lennicke C & Cochemé HM Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol. Cell 81, 3691–3707 (2021). - PubMed
-
- Winterbourn CC The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells. Biochim. Biophys. Acta 1840, 730–738 (2014). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS117000/NS/NINDS NIH HHS/United States
- U01 AI156924/AI/NIAID NIH HHS/United States
- R01 ES028096/ES/NIEHS NIH HHS/United States
- T32 AG052374/AG/NIA NIH HHS/United States
- R01 NS076511/NS/NINDS NIH HHS/United States
- U01 AI156923/AI/NIAID NIH HHS/United States
- R01 ES003598/ES/NIEHS NIH HHS/United States
- R01 AI145406/AI/NIAID NIH HHS/United States
- R56 ES003598/ES/NIEHS NIH HHS/United States
- R01 CA165065/CA/NCI NIH HHS/United States
- 220257/Z/20/Z/WT_/Wellcome Trust/United Kingdom
- R37 NS061817/NS/NINDS NIH HHS/United States
- R01 CA266342/CA/NCI NIH HHS/United States
- R35 HL135828/HL/NHLBI NIH HHS/United States
- R01 NS061817/NS/NINDS NIH HHS/United States
- MC_UU_00015/3/MRC_/Medical Research Council/United Kingdom
- P01 HL114453/HL/NHLBI NIH HHS/United States
- R01 GM139245/GM/NIGMS NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- IK6 BX005234/BX/BLRD VA/United States
- R01 GM079465/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical